| abstract |
The present invention relates to novel heterocyclic derivatives that can be used as SHP2 inhibitors, in particular to a compound represented by structural formula I or a pharmaceutically acceptable salt thereof, further to a compound represented by structural formula I or a pharmaceutically acceptable salt thereof and Use of its pharmaceutical composition in preparing medicine, especially in preparing medicine for treating, preventing or preventing disease or discomfort mediated by SHP2 activity. |